Helius Medical Technologies Files Proxy Statement

TL;DR

Helius Medical Proxy Statement filed. Vote your shares!

AI Summary

Helius Medical Technologies, Inc. filed a DEF 14A proxy statement on May 31, 2024, for its annual meeting on June 27, 2024. The filing details the company's governance and executive compensation, with a focus on shareholder proposals and director elections. Key information includes the company's fiscal year end of December 31 and its principal business address in Newtown, PA.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership, executive pay, and voting matters, enabling informed participation in corporate governance decisions.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing for a proxy statement, not indicating new financial risks.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

• HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
• 0001140361-24-028367 (filing_id) — Accession Number
• 20240531 (date) — Filing Date
• 20240627 (date) — Meeting Date
• 642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA 18940 (address) — Business Address

FAQ

Key Financial Figures

• $2 — Tiger Management and later grew to over $2 billion in assets under management

Filing Documents

• ny20030020x1_def14a.htm (DEF 14A) — 825KB
• logo_heliusmedical.jpg (GRAPHIC) — 33KB
• logo_heliusmedicalx1.jpg (GRAPHIC) — 27KB
• sig_daneandreeff.jpg (GRAPHIC) — 13KB
• sig_jeffreysmathiesen.jpg (GRAPHIC) — 25KB
• ny20030020x1_pc01.jpg (GRAPHIC) — 650KB
• ny20030020x1_pc02.jpg (GRAPHIC) — 518KB
• ny20030020x1_pvp01x1.jpg (GRAPHIC) — 102KB
• ny20030020x1_pvp02x1.jpg (GRAPHIC) — 105KB
• 0001140361-24-028367.txt ( ) — 2852KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION ​ ​ 14 Summary Compensation Table ​ ​ 14 Narrative Disclosure to Summary Compensation Table ​ ​ 14 Employment Agreement and Arrangements (including Payments upon Termination or Change in Control) ​ ​ 15 Outstanding Equity Awards at December 31, 2023 ​ ​ 20 Non-Employee Director Compensation ​ ​ 21 PAY VERSUS PERFORMANCE ​ ​ 22

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ​ ​ 24 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS ​ ​ 25 PROPOSAL 2 – RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ​ ​ 26 PROPOSAL 3 – ADVISORY VOTE TO APPROVE OUR NAMED EXECUTIVE OFFICERS’ COMPENSATION ​ ​ 28 PROPOSAL 4 – APPROVAL OF AN AMENDMENT TO THE HELUIS MEDICAL TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN ​ ​ 29 PROPOSAL 5 – ADJOURNMENT OF ANNUAL MEETING ​ ​ 37 ADDITIONAL MATTERS ​ ​ 38 Other Matters ​ ​ 38 Householding ​ ​ 38 Requirements for Submission of Stockholder Proposals and Nominations for 2025 Annual Meeting ​ ​ 38 Solicitation by Board; Expenses ​ ​ 38 i TABLE OF CONTENTS HELIUS MEDICAL TECHNOLOGIES, INC. PROXY STATEMENT   2024 ANNUAL MEETING OF STOCKHOLDERS JUNE 27, 2024 QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING Who is soliciting my vote? The Board of Directors (the “ Board ”) of Helius Medical Technologies, Inc. (the “ Company ”, “ we ” or “ us ”) is soliciting your proxy, as a holder of our Class A common stock (the “ Common Stock ”), for use at the 2024 Annual Meeting of Stockholders to be held on Thursday, June 27, 2024, at 9:00 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/HSDT2024 and any adjournment or postponement of such meeting (the “ Annual Meeting ”). We have engaged Alliance Advisors LLC to assist in the solicitation of proxies. The Notice of Annual Meeting of Stockholders, proxy statement and form of proxy card are expected to be first mailed to stockholders of record on or about May 31, 2024. What is the purpose of the Annual Meeting? At the Annual Meeting, you

View Full Filing

View this DEF 14A filing on SEC EDGAR